Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 284211011000036112 | betamethasone acetate + betamethasone sodium phosphate | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 284212011000036118 | betamethasone acetate + betamethasone sodium phosphate (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| betamethasone acetate + betamethasone sodium phosphate | Is a | medicinal product | true | Inferred relationship | Some | ||
| betamethasone acetate + betamethasone sodium phosphate | has intended active ingredient | betamethasone acetate | true | Inferred relationship | Some | 1 | |
| betamethasone acetate + betamethasone sodium phosphate | has intended active ingredient | betamethasone sodium phosphate | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| betamethasone (as sodium phosphate) 2.96 mg/mL + betamethasone (as acetate) 2.71 mg/mL injection, ampoule | Is a | False | betamethasone acetate + betamethasone sodium phosphate | Inferred relationship | Some | |
| betamethasone acetate 3 mg/mL + betamethasone sodium phosphate 3.9 mg/mL (total betamethasone 5.7 mg/mL) injection, ampoule | Is a | True | betamethasone acetate + betamethasone sodium phosphate | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR